Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
NEWLLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Mapping the 2026 nanostructured CO₂ reduction catalyst landscape: single-atom catalysts, copper-based systems, photocatalysts, and AI-driven design across 2014–2024 patent and literature records.
Article | Rapport A 2026 patent and literature landscape of magnetic composite actuator technology: five material clusters, key assignees, emerging directions, and strategic IP implications.
Article | Rapport Explore the 2026 stretchable microfluidic device technology landscape: PDMS platforms, organ-on-chip patents, wearable biosensing, and emerging fabrication directions.
Article | Rapport Explore the 2026 stretchable microfluidic device technology landscape: key materials, patent leaders, application domains, and emerging directions from organ-on-chip to wearable biosensing.
Article | Rapport Micro pulsating heat pipe (micro-PHP) technology is moving from lab to market. Explore the 2026 patent landscape, key innovators, and emerging applications.
Article | Rapport A 2026 landscape of bioinspired suction cup gripper technology: octopus-inspired designs, self-sealing membranes, AI grasp planning, and key research institutions.
Article | Rapport A 2026 technology landscape of nanostructured HER catalysts: TMDs, single-atom catalysts, high-entropy alloys, and carbon scaffolds driving green hydrogen at industrial scale.
Article | Rapport Aldosterone synthase inhibitors, AVS alternatives, and cure approaches in the primary hyperaldosteronism pipeline — from CYP11B2 inhibitors to PET imaging.
Article | Rapport A 2026 technology landscape of magnetic particle chain actuators: patent signals, key clusters, geographic trends, and strategic IP implications for R&D teams.
Article | Rapport Fetal hemoglobin induction, luspatercept expansion, and gene editing in the beta-thalassemia drug pipeline — patent signals, clinical data, and strategic implications.
Article | Rapport Mapping the 2026 optical fiber displacement sensor landscape: four sensing clusters, key assignees, geographic trends, and five emerging directions from patent and literature analysis.
Article | Rapport Explore the AL amyloidosis drug pipeline: daratumumab combinations, birtamimab, CAEL-101, CAR-T, and emerging organ-protection strategies shaping rare disease R&D.
Article | Rapport A 2026 patent and literature landscape of electrochemical bromine recovery: membrane flow cells, battery recycling, flow batteries, and emerging IP signals.
Article | Rapport Fibril clearance antibodies, SAP depletion, and cardiac remodeling approaches in the ATTR cardiac amyloidosis drug pipeline — patent signals and clinical evidence.
Article | Rapport Explore the 2026 photonic QKD technology landscape: key protocols, distance records, chip-scale integration, and strategic IP implications from 20+ years of patent data.